Due to the multifactorial pathophysiologies responsible for the symptoms of irritable bowel syndrome (IBS), treatment requires knowledge of the distinct properties of the current approved medications along with the individual patient profile.
In a new study, researchers aimed to compare the real-world effectiveness and associated economic outcomes of two diabetes therapies: liraglutide, an injectable glucagon-like peptide-1 (GLP-1) receptor agonist and sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor.
High doses of fish oil supplements won't prevent recurrence of atrial fibrillation (AF), researchers report.
Trastuzumab (Herceptin) is the best drug treatment for human epidermal growth factor receptor 2-positive breast cancer and should remain the standard of care for that type of tumor, according to new research.
Forty states and the District of Columbia now have a total of 277 confirmed cases of Enterovirus D68, the severe respiratory illness that typically targets children, U.S. health officials are reporting
The risks of opioids outweigh their benefits for treating chronic noncancer pain such as chronic headaches, low back pain, and fibromyalgia, according to a new statement from the American Academy of Neurology (AAN).
Doctors need to make sure patients understand the radiation-related risks of heart imaging tests before sending them for such procedures, a new American Heart Association scientific statement says.
Children who are given broad-spectrum antibiotics before the age of 2 may face a slightly higher risk of becoming obese during childhood.
Patients are receiving medical implants that may not have been rigorously tested before or after their approval by the U.S. Food and Drug Administration, two new studies contend.
For critically ill patients in intensive care units (ICUs) with vitamin D deficiency, vitamin D3 treatment has minimal health benefits, according to a new study.